10/23/2018 1:06:59 PM - Gapped up on M&A news 8/15/18 and it has been hovering near its all-time high. Completed a new Public Offering on 10/20/17. Reported Jul '18 quarterly earnings +83% on +27% sales revenues, marking the 7th consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria.
8/30/2018 12:54:41 PM - Gapped up on M&A news 8/15/18 and it has been hovering near its all-time high. Completed a new Public Offering on 10/20/17. Reported Apr '18 quarterly earnings +108% on +45% sales revenues, marking the 6th consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria.
8/27/2018 12:32:40 PM - Gapped up on M&A news 8/15/18 and it has been hovering near its all-time high. Completed a new Public Offering on 10/20/17. Reported Apr '18 quarterly earnings +108% on +45% sales revenues, marking the 6th consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria.
8/24/2018 12:53:36 PM - Gapped up on M&A news 8/15/18 and it has been hovering near its all-time high. Completed a new Public Offering on 10/20/17. Reported Apr '18 quarterly earnings +108% on +45% sales revenues, marking the 6th consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria.
8/22/2018 12:49:01 PM - Gapped up on M&A news 8/15/18 and it has been hovering near its all-time high. Completed a new Public Offering on 10/20/17. Reported Apr '18 quarterly earnings +108% on +45% sales revenues, marking the 6th consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria.
8/21/2018 1:04:21 PM - Gapped up on M&A news 8/15/18 and it has been hovering near its all-time high. Completed a new Public Offering on 10/20/17. Reported Apr '18 quarterly earnings +108% on +45% sales revenues, marking the 6th consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria.
8/20/2018 12:10:59 PM - Gapped up on M&A news 8/15/18 and it has been hovering near its all-time high. Completed a new Public Offering on 10/20/17. Reported Apr '18 quarterly earnings +108% on +45% sales revenues, marking the 6th consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria.
8/17/2018 12:32:17 PM - Gapped up on 8/15/18 challenging its all-time high with a considerable volume-driven gain. Completed a new Public Offering on 10/20/17. Reported Apr '18 quarterly earnings +108% on +45% sales revenues, marking the 6th consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria.
8/16/2018 11:55:36 AM - Gapped up on the prior session challenging its all-time high with a considerable volume-driven gain. Completed a new Public Offering on 10/20/17. Reported Apr '18 quarterly earnings +108% on +45% sales revenues, marking the 6th consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria.
8/15/2018 12:04:28 PM - Gapped up today challenging its all-time high with a considerable volume-driven gain. Completed a new Public Offering on 10/20/17. Reported Apr '18 quarterly earnings +108% on +45% sales revenues, marking the 6th consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria.
6/13/2018 12:44:39 PM - Gapped up hitting another new all-time high on the prior session with a 3rd consecutive volume-driven gain. Completed a new Public Offering on 10/20/17. Reported Apr '18 quarterly earnings +108% on +45% sales revenues, marking the 6th consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria.
6/12/2018 12:50:32 PM - Gapped up hitting another new all-time high with today's 3rd consecutive volume-driven gain. Completed a new Public Offering on 10/20/17. Reported Jan '18 quarterly earnings +82% on +44% sales revenues, marking the 5th consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria.
6/11/2018 12:25:53 PM - Hitting a new all-time high with today's gain so no resistance remains due to overhead supply. Completed a new Public Offering on 10/20/17. Reported Jan '18 quarterly earnings +82% on +44% sales revenues, marking the 5th consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria.
5/29/2018 12:28:27 PM - Consolidating near its all-time high with little resistance remaining due to overhead supply. Completed a new Public Offering on 10/20/17. Reported Jan '18 quarterly earnings +82% on +44% sales revenues, marking the 5th consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Fundamental concerns remain and it was noted with caution in prior mid-day reports - "Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria."
3/12/2018 12:23:29 PM - Gapped up for a big gain and new all-time high on the prior session with its 6th consecutive gain with ever-increasing volume. No resistance remains due to overhead supply. Completed a new Public Offering on 10/20/17. Reported Jan '18 quarterly earnings +82% on +44% sales revenues, marking the 5th consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Fundamental concerns remain and it was noted with caution in prior mid-day reports - "Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria."
3/9/2018 12:40:12 PM - Gapped up for a big gain today challenging its all-time high with a 6th consecutive gain with ever-increasing volume. No resistance remains due to overhead supply. Completed a new Public Offering on 10/20/17. Reported Jan '18 quarterly earnings +82% on +44% sales revenues, marking the 5th consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Fundamental concerns remain and it was noted with caution in prior mid-day reports - "Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria."
12/14/2017 12:19:18 PM - No resistance remains due to overhead supply. Gapped up and rallied into new all-time high territory with considerable volume-driven gains this week. Found support near its 50 DMA line ($54.66) after completing a new Public Offering on 10/20/17. Reported Oct '17 quarterly earnings +73% on +45% sales revenues, marking the 4th consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Noted with caution in prior mid-day reports - "Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria."
12/13/2017 12:50:56 PM - No resistance remains due to overhead supply. Gapped up on the prior session and rallied further today hitting new all-time highs with considerable volume-driven gains. Found support near its 50 DMA line ($54.48) after completing a new Public Offering on 10/20/17. Reported Oct '17 quarterly earnings +73% on +45% sales revenues, marking the 4th consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Noted with caution in prior mid-day reports - "Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria."
12/12/2017 12:49:17 PM - Gapped up today hitting a new all-time high with a considerable volume-driven gain. Found support near its 50 DMA line ($54.30) after completing a new Public Offering on 10/20/17. No resistance remains due to overhead supply. Reported Oct '17 quarterly earnings +73% on +45% sales revenues, marking the 4th consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Last noted with caution in the 11/13/17 mid-day report - "Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria."
11/13/2017 12:56:15 PM - Consolidating near its 50 DMA line ($52.90) after completing a new Public Offering on 10/20/17. Abruptly retreated after challenging its all-time high. Prior mid-day reports cautioned members - "Little resistance remains due to overhead supply. Reported Jul '17 quarterly earnings +82% on +28% sales revenues, marking the 3rd consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria."
11/10/2017 12:28:41 PM - Consolidating after completing a new Public Offering on 10/20/17, it abruptly retreated after challenging its all-time high. Prior mid-day reports cautioned members - "Little resistance remains due to overhead supply. Reported Jul '17 quarterly earnings +82% on +28% sales revenues, marking the 3rd consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria."
10/30/2017 1:40:06 PM - Consolidating after completing a new Public Offering on 10/20/17, it abruptly retreated after challenging its all-time high. Prior mid-day reports cautioned members - "Little resistance remains due to overhead supply. Reported Jul '17 quarterly earnings +82% on +28% sales revenues, marking the 3rd consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria."
10/20/2017 12:42:27 PM - Proposed a new Public Offering and gapped down on 10/18/17, abruptly retreating from its all-time high. Prior mid-day reports cautioned members - "Little resistance remains due to overhead supply. Reported Jul '17 quarterly earnings +82% on +28% sales revenues, marking the 3rd consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria."
10/19/2017 12:55:33 PM - Proposed a new Public Offering and gapped down on the prior session, abruptly retreating from near its all-time high. Prior mid-day reports cautioned members - "Little resistance remains due to overhead supply. Reported Jul '17 quarterly earnings +82% on +28% sales revenues, marking the 3rd consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria."
10/18/2017 1:20:38 PM - Proposed a new Public Offering and gapped down today, abruptly retreating. Perched near its all-time high with a big volume-driven gain, the 10/17/17 mid-day report cautioned members - "Little resistance remains due to overhead supply. Reported Jul '17 quarterly earnings +82% on +28% sales revenues, marking the 3rd consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria."
10/17/2017 12:53:44 PM - Gapped up, rebounding toward its all-time high with today's big volume-driven gain. Little resistance remains due to overhead supply. Reported Jul '17 quarterly earnings +82% on +28% sales revenues, marking the 3rd consecutive quarter with an earnings increase meeting the fact-based investment system's +25% minimum guideline (C criteria). Prior downturn in FY '13 and '14 earnings is a flaw concerning the A criteria.
6/9/2017 1:24:35 PM - Retreating from its all-time high with today's volume-driven loss. Reported Apr '17 quarterly earnings +29% on +9% sales revenues, however fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines.
6/8/2017 1:16:32 PM - Hitting a new all-time high with today's volume-driven gain. Due to report Apr '17 quarterly results tomorrow before the open. The 5/01/17 mid-day report last cautioned - "Reported Jan '17 earnings +43% on +12% sales however fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
5/1/2017 1:02:53 PM - Hitting new all-time highs with today's 6th consecutive volume-driven gain. Held its ground above prior highs during its consolidation since a big gap up on 3/14/17. Prior mid-day reports cautioned members - "Reported Jan '17 earnings +43% on +12% sales however fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
4/26/2017 12:48:58 PM - Hit a new all-time high with a big volume-driven gain on the prior session. Held its ground above prior highs during its consolidation since a big gap up on 3/14/17. Prior mid-day reports cautioned members - "Reported Jan '17 earnings +43% on +12% sales however fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
4/25/2017 12:18:56 PM - Hitting a new all-time high with today's big volume-driven gain. Held its ground above prior highs during its consolidation since a big gap up on 3/14/17. Prior mid-day reports cautioned members - "Reported Jan '17 earnings +43% on +12% sales however fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
4/6/2017 12:43:16 PM - Consolidating near its all-time high following volume-driven gains. Held its ground above prior highs during its consolidation since a big gap up on 3/14/17. Prior mid-day reports cautioned members - "Reported Jan '17 earnings +43% on +12% sales however fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
4/3/2017 11:59:53 AM - Retreating today from a new all-time high following 4 consecutive volume-driven gains. Held its ground above prior highs during its consolidation since a big gap up on 3/14/17. Prior mid-day reports cautioned members - "Reported Jan '17 earnings +43% on +12% sales however fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
3/31/2017 12:54:01 PM - Hitting a new all-time high with today's 4th consecutive volume-driven gain. Held its ground above prior highs during its consolidation since a big gap up on 3/14/17. Prior mid-day reports cautioned members - "Reported Jan '17 earnings +43% on +12% sales however fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
3/30/2017 12:57:03 PM - Held its ground above prior highs during its consolidation since a big gap up on 3/14/17. Prior mid-day reports cautioned members - "Reported Jan '17 earnings +43% on +12% sales however fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
3/29/2017 12:40:30 PM - Consolidating since a big gap up on 3/14/17 for a new all-time high. Prior mid-day reports cautioned members - "Reported Jan '17 earnings +43% on +12% sales however fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
3/28/2017 12:37:53 PM - Stubbornly holding its ground since a big gap up on 3/14/17 hitting new all-time highs. Prior mid-day reports cautioned members - "Reported Jan '17 earnings +43% on +12% sales however fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
3/20/2017 1:02:13 PM - Stubbornly holding its ground since a big gap up on 3/14/17 hitting new all-time highs. Prior mid-day reports cautioned members - "Reported Jan '17 earnings +43% on +12% sales however fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
3/17/2017 12:27:22 PM - Stubbornly holding its ground since a big gap up on 3/14/17 hitting new all-time highs. Prior mid-day reports cautioned members - "Reported Jan '17 earnings +43% on +12% sales however fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
3/16/2017 12:55:44 PM - Consolidating since a big gap up on 3/14/17 hitting new all-time highs. Prior mid-day reports cautioned members - "Reported Jan '17 earnings +43% on +12% sales however fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
3/15/2017 1:04:24 PM - Gapped up on the prior session hitting new all-time highs and the mid-day report cautioned - "Reported Jan '17 earnings +43% on +12% sales however fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
3/14/2017 12:40:54 PM - Gapped up today hitting new all-time highs. Reported Jan '17 earnings +43% on +12% sales however fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines.
1/4/2017 12:41:41 PM - Perched at its all-time high following a streak of volume-driven gains. Prior mid-day reports repeatedly cautioned - "Reported Oct '16 earnings +14% on +0% sales and fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
1/3/2017 12:31:02 PM - Perched at its all-time high following a streak of volume-driven gains. Prior mid-day reports repeatedly cautioned - "Reported Oct '16 earnings +14% on +0% sales and fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
12/28/2016 12:26:50 PM - Perched at 52-week and all-time highs today following a streak of volume-driven gains. Prior mid-day reports cautioned - "Reported Oct '16 earnings +14% on +0% sales and fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
12/27/2016 12:18:55 PM - Perched at 52-week and all-time highs today following a streak of volume-driven gains. Prior mid-day reports cautioned - "Reported Oct '16 earnings +14% on +0% sales and fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
12/20/2016 12:33:08 PM - Perched at 52-week and all-time highs today following a streak of volume-driven gains. Prior mid-day reports cautioned - "Reported Oct '16 earnings +14% on +0% sales and fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
12/15/2016 12:13:56 PM - Perched at 52-week and all-time highs today following a streak of gains. Prior mid-day reports cautioned - "Reported Oct '16 earnings +14% on +0% sales and fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
12/14/2016 12:27:47 PM - Perched near new 52-week and all-time highs today following a streak of gains. Reported Oct '16 earnings +14% on +0% sales and fundamental concerns remain. Prior mid-day reports cautioned - "The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
12/12/2016 12:23:50 PM - Hitting new 52-week and all-time highs with a streak of gains. Prior mid-day reports cautioned members - "Reported Jul '16 earnings +19% on -1% sales and fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
12/9/2016 12:22:37 PM - Hitting new 52-week and all-time highs with a streak of gains. Prior mid-day reports cautioned members - "Reported Jul '16 earnings +19% on -1% sales and fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
10/17/2016 12:17:06 PM - Found support and rebounded above its 50 DMA line with a big volume-driven gain when the 10/14/16 mid-day report cautioned members - "Reported Jul '16 earnings +19% on -1% sales and fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
10/14/2016 12:20:12 PM - Found support and rebounded above its 50 DMA line with today's volume-driven gain. Reported Jul '16 earnings +19% on -1% sales and fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines.
7/15/2016 12:47:59 PM - Found support above its 50 DMA line and prior highs while consolidating since the 6/15/16 mid-day report cautioned members - "Reported Apr '16 earnings +17% on +2% sales and fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
7/12/2016 12:20:40 PM - Found support above its 50 DMA line and prior highs while consolidating since the 6/15/16 mid-day report cautioned members - "Reported Apr '16 earnings +17% on +2% sales and fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
7/11/2016 12:19:09 PM - Found support above its 50 DMA line and prior highs while consolidating since the 6/15/16 mid-day report cautioned members - "Reported Apr '16 earnings +17% on +2% sales and fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
7/8/2016 12:28:25 PM - Found support above its 50 DMA line and prior highs while consolidating since the 6/15/16 mid-day report cautioned members - "Reported Apr '16 earnings +17% on +2% sales and fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
7/7/2016 12:11:25 PM - Found support above its 50 DMA line and prior highs while consolidating since the 6/15/16 mid-day report cautioned members - "Reported Apr '16 earnings +17% on +2% sales and fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
7/6/2016 12:29:44 PM - Found support above its 50 DMA line and prior highs while consolidating since the 6/15/16 mid-day report cautioned members - "Reported Apr '16 earnings +17% on +2% sales and fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
7/5/2016 12:31:20 PM - Found support above its 50 DMA line and prior highs while consolidating since the 6/15/16 mid-day report last cautioned members - "Reported Apr '16 earnings +17% on +2% sales and fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
6/15/2016 12:24:04 PM - The 6/10/16 mid-day report cautioned - "Reported Apr '16 earnings +17% on +2% sales and fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines."
6/10/2016 12:22:22 PM - Reported Apr '16 earnings +17% on +2% sales and fundamental concerns remain. The Chemicals - Specialty firm is not a match with the fact-based investment system's C and A guidelines.
6/2/2006 12:35:31 PM - No base.
5/17/2006 12:47:58 PM - No base.
5/16/2006 12:43:36 PM - No base.
5/12/2006 12:34:30 PM - No base.